CAS: 1104874-94-3

MHP (Methyl caprooyl tyrosinate) is an activator of sphingosine kinase (SPHK1), and significantly stimulates CAMP mRNA and protein production in KC.

Defensamide (MHP) is a hydrogen-bonded molecule that has been identified as an inhibitor of the enzyme fatty acid synthase. Defensamide (MHP) is a competitive inhibitor of the model system and inhibits the reaction mechanism of fatty acid synthase. It has been shown to have therapeutic potential for patients with Parkinson’s disease, seasonal affective disorder, and Alzheimer’s disease. Defensamide (MHP) also has a role in lipid metabolism and energy metabolism. Defensamide (MHP) can be used as a marker for air entrainment in perennial ryegrass. The localization of this molecule has been determined to be within the hippocampal formation and gene product. Defensamide (MHP) interacts with peptide hormones such as vasopressin, oxytocin, and gonadotropin-releasing hormone receptor. The binding site for benzalkonium chloride at the active site of defensamide is

MHP

(S)-Methyl 2-Hexanamido-3-(4-Hydroxyphenyl)Propanoate